Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
New Hampshire GLP-1 Coverage
Health
April 22, 2026 Evan Vega

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.

Read More
FDA Approves Alzheimer's Bloodtest
Health
April 22, 2026 Evan Vega

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

The FDA approved the Lumipulse G pTau217/ß-Amyloid 1-42 blood test for early Alzheimer’s detection in adults 55+ with cognitive decline.

Read More
Digital brain connected to a laptop via glowing neural networks, illustrating the evolution of Second Brain for AI.
Health
April 22, 2026 Evan Vega

The Open Brain Manifesto: Why Second Brain Is Being Redefined for AI

The ‘second brain’ category has been captured for a decade by note-taking apps. But once AI becomes the primary reader of the archive, the architecture has to change. The open brain is what comes next

Read More
Medicare Medicaid Fraud Investigation
Health
April 21, 2026 Evan Vega

House Energy & Commerce Committee Probes Medicare and Medicaid Fraud in Provider Hearings

Republican leaders on the House Energy & Commerce Committee expanded their Medicaid fraud probe by contacting officials in 10 states, including California and New York.

Read More
Trump health care fraud
Health
April 21, 2026 Evan Vega

Trump Administration Launches Task Force to Eliminate Health Care Fraud Nationwide

President Trump signed an order creating a task force led by VP J.D. Vance to combat fraud in federal health care and benefit programs.

Read More
Antiretroviral Therapy Slows Aging
Health
April 20, 2026 Evan Vega

Antiretroviral Therapy Reduces Biological Aging in HIV Patients by Nearly Four Years, Study Finds

Antiretroviral therapy reduces biological aging in HIV patients by nearly four years, showing recovery through the Proteomic Age Clock.

Read More
Sickle Cell Treatment Success
Health
April 20, 2026 Evan Vega

Novo Nordisk’s Sickle Cell Treatment Shows 27% Reduction in Vaso-Occlusive Crises, FDA Approval Expected Later in 2026

Novo Nordisk’s etavopivat reduced vaso-occlusive crises by 27% in Phase 3 trial for sickle cell disease; FDA approval expected in late 2026.

Read More
Mental Health Coverage Gaps
Health
April 18, 2026 Evan Vega

AMA-Backed Mental Health Parity Index Tool Reveals Real-Time Gaps in Insurance Coverage and Payments

The AMA-backed Mental Health Parity Index tool reveals real-time insurance coverage and payment gaps for mental health across 43 states and 70% of counties.

Read More
Hospital struggles covering Ozempic
Health
April 18, 2026 Evan Vega

Hospital Chain Struggles to Cover GLP-1 Weight Loss Drugs Like Ozempic for Employee Health Plans

A major U.S. hospital chain faced challenges covering GLP-1 weight loss drugs like Ozempic in employee health plans amid rising costs.

Read More
Late-Stage Syphilis Risks
Health
April 18, 2026 Evan Vega

Researchers Link Late-Stage Syphilis to Elevated Risks of Stroke, Heart Attack and Death in US Adults

A study links late-stage syphilis in U.S. adults to higher risks of stroke, heart attack, and nearly sixfold increased mortality rates.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.